Panacea Biotec Annual Results

FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	Mar-2022	Mar-2021	Mar-2020	Mar-2019	Mar-2018
Gross Sales	661.23	624.81	544.06	456.70	596.16
Excise Duty	--	--	--	--	3.37
Net Sales	661.23	624.81	544.06	456.70	592.79
Other Operating Income	--	--	--	--	--
Other Income	1687.18	10.06	30.02	338.64	7.99
Total Income	2348.41	634.87	574.08	795.34	600.78
Total Expenditure	675.09	549.62	534.53	591.13	509.06
PBIDT	1673.32	85.25	39.55	204.21	91.72
Interest	180.84	185.34	173.98	104.83	100.58
PBDT	1492.48	(100.09)	(134.43)	99.38	(8.86)
Depreciation	43.66	45.60	43.22	54	57.28
Minority Interest Before NP	--	--	--	--	--
Tax	400.73	2.32	39.96	7.55	1.09
Deferred Tax	(29.82)	(0.36)	(23.32)	0.16	8.77
Reported Profit After Tax	1077.91	(147.65)	(194.29)	37.67	(76)
Minority Interest After NP	--	0.04	--	--	--
Net Profit after Minority Interest	1077.91	(147.69)	(194.29)	37.67	(76)
Extra-ordinary Items	1275.48	--	(11.81)	326.30	--
Adjusted Profit After Extra-ordinary item	(197.57)	(147.69)	(182.48)	(288.63)	(76)
EPS (Unit Curr.)	175.98	(24.11)	(31.72)	6.15	(12.41)
Book Value (Unit Curr.)	--	--	--	--	--
Dividend (%)	--	--	--	--	--
Equity	6.13	6.13	6.13	6.13	6.13
Public Shareholding (Number)	--	--	--	--	--
Public Shareholding (%)	--	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--	--
PBIDTM(%)	253.06	13.64	7.27	44.71	15.47
PBDTM(%)	225.71	(16.02)	(24.71)	21.76	(1.50)
PATM(%)	163.02	(23.63)	(35.71)	8.25	(12.82)